Company Information for DESTINA GENOMICS LTD
7-11 MELVILLE STREET, EDINBURGH, EH3 7PE,
|
Company Registration Number
SC377695
Private Limited Company
Active |
Company Name | |
---|---|
DESTINA GENOMICS LTD | |
Legal Registered Office | |
7-11 MELVILLE STREET EDINBURGH EH3 7PE Other companies in EH3 | |
Company Number | SC377695 | |
---|---|---|
Company ID Number | SC377695 | |
Date formed | 2010-04-28 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2022 | |
Account next due | 30/09/2024 | |
Latest return | 28/04/2016 | |
Return next due | 26/05/2017 | |
Type of accounts | TOTAL EXEMPTION FULL | |
VAT Number /Sales tax ID | GB102207872 |
Last Datalog update: | 2023-09-05 17:15:08 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
JORGE BENSADON BELICHA |
||
JUAN DIAZ-MOCHON |
||
HUGH ALEXANDER ILYINE |
||
DAVID MARK WHITCOMBE |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
CELLBIO LIMITED | Director | 2009-11-23 | CURRENT | 2009-11-23 | Active | |
CYTOX LIMITED | Director | 2017-06-26 | CURRENT | 2004-06-09 | Liquidation | |
NANOFLEX EMPLOYEE TRUSTEE LTD | Director | 2014-07-04 | CURRENT | 2014-07-04 | Active - Proposal to Strike off | |
NANOFLEX LIMITED | Director | 2012-04-03 | CURRENT | 2008-01-30 | Liquidation | |
CLARITY NOW LIMITED | Director | 2002-06-02 | CURRENT | 2002-06-02 | Active |
Date | Document Type | Document Description |
---|---|---|
APPOINTMENT TERMINATED, DIRECTOR JAN GROEN | ||
CONFIRMATION STATEMENT MADE ON 28/04/23, WITH UPDATES | ||
31/12/21 ACCOUNTS TOTAL EXEMPTION FULL | ||
APPOINTMENT TERMINATED, DIRECTOR JORGE BENSADON BELICHA | ||
CONFIRMATION STATEMENT MADE ON 28/04/22, WITH UPDATES | ||
CS01 | CONFIRMATION STATEMENT MADE ON 28/04/22, WITH UPDATES | |
AA | 31/12/20 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/04/21, WITH UPDATES | |
CH01 | Director's details changed for Mr Todd Snowden on 2021-04-28 | |
AA01 | Previous accounting period shortened from 31/03/21 TO 31/12/20 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR HUGH ALEXANDER ILYINE | |
AA | 31/03/20 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/04/20, WITH UPDATES | |
AP01 | DIRECTOR APPOINTED MR TODD SNOWDEN | |
CH01 | Director's details changed for Dr Juan Diaz-Mochon on 2020-04-22 | |
AA | 31/03/19 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/04/19, WITH NO UPDATES | |
AA | 31/03/18 ACCOUNTS TOTAL EXEMPTION FULL | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/04/18, WITH UPDATES | |
AA | 31/03/17 ACCOUNTS TOTAL EXEMPTION FULL | |
LATEST SOC | 17/05/17 STATEMENT OF CAPITAL;GBP 27.63 | |
SH01 | 03/05/17 STATEMENT OF CAPITAL GBP 27.630 | |
RES10 | Resolutions passed:
| |
RES01 | ADOPT ARTICLES 27/04/2017 | |
CS01 | CONFIRMATION STATEMENT MADE ON 28/04/17, WITH UPDATES | |
AA | 31/03/16 ACCOUNTS TOTAL EXEMPTION SMALL | |
LATEST SOC | 28/04/16 STATEMENT OF CAPITAL;GBP 24.911 | |
AR01 | 28/04/16 ANNUAL RETURN FULL LIST | |
AA | 31/03/15 ACCOUNTS TOTAL EXEMPTION SMALL | |
AP01 | DIRECTOR APPOINTED DAVID WHITCOMBE | |
AP01 | DIRECTOR APPOINTED JORGE BENSADON BELICHA | |
LATEST SOC | 29/04/15 STATEMENT OF CAPITAL;GBP 19.925 | |
AR01 | 28/04/15 ANNUAL RETURN FULL LIST | |
AA | 31/03/14 ACCOUNTS TOTAL EXEMPTION SMALL | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES01 | ADOPT ARTICLES 03/07/2014 | |
SH01 | 04/07/14 STATEMENT OF CAPITAL GBP 24.911 | |
AR01 | 28/04/14 FULL LIST | |
AA | 31/03/13 TOTAL EXEMPTION SMALL | |
AD01 | REGISTERED OFFICE CHANGED ON 12/09/2013 FROM MITCHELL HALL MITCHELLBRAE ROAD HADDINGTON EAST LOTHIAN EH41 4LB UNITED KINGDOM | |
AR01 | 28/04/13 FULL LIST | |
AA | 31/03/12 TOTAL EXEMPTION SMALL | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
SH01 | 14/08/12 STATEMENT OF CAPITAL GBP 19.925 | |
AR01 | 28/04/12 FULL LIST | |
AA | 31/03/11 TOTAL EXEMPTION SMALL | |
AD01 | REGISTERED OFFICE CHANGED ON 14/11/2011 FROM MITCHELL HALL MITCHELLBRAE ROAD HADDINGTON EAST LOTHION EH41 4RF SCOTLAND | |
AD01 | REGISTERED OFFICE CHANGED ON 13/09/2011 FROM 12 NILE GROVE EDINBURGH EH10 4RF UNITED KINGDOM | |
AR01 | 28/04/11 FULL LIST | |
AA01 | PREVSHO FROM 30/04/2011 TO 31/03/2011 | |
SH02 | SUB-DIVISION 04/03/11 | |
RES01 | ADOPT ARTICLES 04/03/2011 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
SH01 | 04/03/11 STATEMENT OF CAPITAL GBP 14.48 | |
RES01 | ADOPT ARTICLES 01/12/2010 | |
SH01 | 01/12/10 STATEMENT OF CAPITAL GBP 10.00 | |
SH01 | 01/12/10 STATEMENT OF CAPITAL GBP 12.50 | |
SH01 | 10/11/10 STATEMENT OF CAPITAL GBP 9.25 | |
SH02 | SUB-DIVISION 07/10/10 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
SH01 | 07/10/10 STATEMENT OF CAPITAL GBP 714 | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max | |
MortgagesNumMortCharges | 0.33 | 8 |
MortgagesNumMortOutstanding | 0.17 | 8 |
MortgagesNumMortPartSatisfied | 0.00 | 1 |
MortgagesNumMortSatisfied | 0.16 | 8 |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on DESTINA GENOMICS LTD
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as DESTINA GENOMICS LTD are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Category | Award/Grant | |
---|---|---|
Feasibility of a rapid, sensitive, nucleic acid based test for detection and serotyping of enteric viruses of human health importance : Feasibility Study | 2012-12-01 | £ 74,958 |
Detection of bovine mastitis pathogens using novel nucleic acid testing technology : Feasibility Study | 2012-08-01 | £ 24,750 |
Novel nucleic acid detection for determining norovirus levels in food : Feasibility Study | 2011-05-01 | £ 15,000 |
Novel companion biomarker assay for glioma cancer drug development to overcome current lack of in-vitro test success : Feasibility Study | 2011-05-01 | £ 9,041 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |